Inventor

SIERKS MICHAEL

US19 patents

⚠️ This page may combine multiple inventors who share the name “SIERKS MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SIERKS MICHAEL

UNIV ARIZONA STATE

Antibody based reagents that specifically recognize toxic oligomeric forms of tau

Nanoscale process to generate reagents selective for individual protein variants

Antibody based reagents that specifically recognize neurodegenerative disease related forms of the protein TDP-43

Antibody based reagents that specifically recognize neurodegenerative disease related forms of the protein TDP-43

Antibody based reagents that specifically recognize toxic oligomeric forms of tau

DARPin reagents that distinguish Alzheimer&#39;s disease and Parkinson&#39;s disease samples

Methods for detecting traumatic brain injury

Antibody based reagents that specifically recognize neurodegenerative disease related forms of the protein TDP-43

Antibody based reagents that specifically recognize toxic oligomeric forms of tau

Human alzheimer&#39;s disease and traumatic brain injury associated tau variants as biomarkers and methods of use thereof

Antibody based reagents that specifically recognize toxic oligomeric forms of tau

SIERKS MICHAEL

Bispecific nanobodies as a therapeutic for alzheimer&#39;s disease

Antibody based reagent that specifically recognizes toxic oligomeric form of beta-amyloid

Immunization with amyloid-beta oligomers

ARIZONA BOARD OF REGENTS A BODY CORP OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STA

Bispecific antibody fragments for neurological disease proteins and methods of use

ARIZONA BOARD OF REGENTS A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZON

Nanoscale process to generate reagents selective for individual protein variants

UNIV IOWA STATE RES FOUND

Process for enzymatic hydrolysis of starch to glucose

UNIV MARYLAND

Method for increasing the hydrolytic activity of starch hyrdolases

ARIZONA BOARD OF REGENTS A BODY CORP OF THE STATE OF ARIZONA

Bispecific antibody fragments for neurological disease proteins and methods of use

DARPin reagents that distinguish Alzheimer's disease and Parkinson's disease samples

Human alzheimer's disease and traumatic brain injury associated tau variants as biomarkers and methods of use thereof

Bispecific nanobodies as a therapeutic for alzheimer's disease